ArticleCancer drug resistance (Alhambra, Calif.)2025

KLF5 promotes tumor proliferation and oxaliplatin resistance via chromatin remodeling in KRAS-mutated colorectal cancer.

Zhuoqing Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.